1
/
의
1
AntibodySystem
SKU(재고 관리 코드):KDJ65301
Dilpacimab ELISA Kit
Dilpacimab ELISA Kit
Catalog No.: KDJ65301
| Catalog No. | KDJ65301 |
|---|---|
| Product name | Dilpacimab ELISA Kit |
| Size | 96 T |
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Detection method | Colorimetric |
| Precision | CV<20% |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 0.156 μg/ml |
| Range | 0.31-5 μg/mL |
| Recovery | 80-120% |
| Background | Dilpacimab (formerly ABT-165), a novel dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways. Here, we present safety, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy data from a phase I study (trial registration ID: NCT01946074) of dilpacimab in patients with advanced solid tumors. Eligible patients (≥18 years) received dilpacimab intravenously on days 1 and 15 in 28-day cycles at escalating dose levels (range, 1.25–7.5 mg/kg) until progressive disease or unacceptable toxicity. |
| Alternative Names | ABT-165, PR-1283233, CAS: 1791420-09-1 |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Share
